Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant

NCT00171379 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Acute Rejection After Kidney Transplantation

Interventions

DRUG: Enteric-Coated Mycophenolate Sodium

Sponsor

Novartis